Global Genome Engineering Market by Technology, Application, End-User - Forecast 2024-2030- Product Image

Sale

Global Genome Engineering Market by Technology, Application, End-User - Forecast 2024-2030

Report
191 Pages
March 2024
Region: Global
360iResearch™
ID: 4904586

UP TO €846EUR$875USD£727GBP OFF until Dec 31^st 2024

The Genome Engineering Market size was estimated at USD 6.33 billion in 2023, USD 7.32 billion in 2024, and is expected to grow at a CAGR of 15.68% to reach USD 17.57 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Genome Engineering Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Genome Engineering Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Genome Engineering Market, highlighting leading vendors and their innovative profiles. These include Bluebird Bio, Inc., CRISPR Therapeutics AG, Danaher Corporation, Editas Medicine, Inc., GenScript Biotech Corporation, Horizon Discovery Group PLC, Intellia Therapeutics, Inc., Lonza Group AG, Merck & Co., Inc., New England Biolabs, Origene Technologies, Precision BioSciences, Inc., Sangamo Therapeutics, Inc., Thermo Fisher Scientific Inc., and Transposagen Biopharmaceuticals, Inc.

Market Segmentation & Coverage

This research report categorizes the Genome Engineering Market to forecast the revenues and analyze trends in each of the following sub-markets:

Technology
- Clustered Regularly Interspaced Short Palindromic Repeats
- Transcription Activator-like Effector Nuclease
- Zinc Finger Nuclease
Application
- Animal Genetic Engineering
- Cell Line Engineering
- Plant Genome Engineering
End-User
- Academic & Government Research Institutes
- Biotechnology & Pharmaceutical Companies
- Contract Research Organizations

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

What is the market size and forecast of the Genome Engineering Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Genome Engineering Market?
What are the technology trends and regulatory frameworks in the Genome Engineering Market?
What is the market share of the leading vendors in the Genome Engineering Market?
Which modes and strategic moves are suitable for entering the Genome Engineering Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Genome Engineering Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand for synthetic gene in biotechnology sector
5.1.1.2. Rising implementation of CRISPR genome editing technology
5.1.1.3. Increasing adoption in diagnostics sector worldwide
5.1.2. Restraints
5.1.2.1. High equipment/systems costs in genome engineering
5.1.3. Opportunities
5.1.3.1. Constant technological developments in gene-editing tools
5.1.3.2. Emerging application in personalized medicine
5.1.4. Challenges
5.1.4.1. Issues associaetd with genetic engineering
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Genome Engineering Market, by Technology

6.1. Introduction
6.2. Clustered Regularly Interspaced Short Palindromic Repeats
6.3. Transcription Activator-like Effector Nuclease
6.4. Zinc Finger Nuclease

7. Genome Engineering Market, by Application

7.1. Introduction
7.2. Animal Genetic Engineering
7.3. Cell Line Engineering
7.4. Plant Genome Engineering

8. Genome Engineering Market, by End-User

8.1. Introduction
8.2. Academic & Government Research Institutes
8.3. Biotechnology & Pharmaceutical Companies
8.4. Contract Research Organizations

9. Americas Genome Engineering Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Genome Engineering Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Genome Engineering Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. Bluebird Bio, Inc.
13.1.2. CRISPR Therapeutics AG
13.1.3. Danaher Corporation
13.1.4. Editas Medicine, Inc.
13.1.5. GenScript Biotech Corporation
13.1.6. Horizon Discovery Group PLC
13.1.7. Intellia Therapeutics, Inc.
13.1.8. Lonza Group AG
13.1.9. Merck & Co., Inc.
13.1.10. New England Biolabs
13.1.11. Origene Technologies
13.1.12. Precision BioSciences, Inc.
13.1.13. Sangamo Therapeutics, Inc.
13.1.14. Thermo Fisher Scientific Inc.
13.1.15. Transposagen Biopharmaceuticals, Inc.
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. GENOME ENGINEERING MARKET RESEARCH PROCESS
FIGURE 2. GENOME ENGINEERING MARKET SIZE, 2023 VS 2030
FIGURE 3. GENOME ENGINEERING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GENOME ENGINEERING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GENOME ENGINEERING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GENOME ENGINEERING MARKET DYNAMICS
FIGURE 7. GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 8. GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GENOME ENGINEERING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GENOME ENGINEERING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. GENOME ENGINEERING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. GENOME ENGINEERING MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. GENOME ENGINEERING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GENOME ENGINEERING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GENOME ENGINEERING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 6. GENOME ENGINEERING MARKET SIZE, BY CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. GENOME ENGINEERING MARKET SIZE, BY TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GENOME ENGINEERING MARKET SIZE, BY ZINC FINGER NUCLEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 10. GENOME ENGINEERING MARKET SIZE, BY ANIMAL GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GENOME ENGINEERING MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GENOME ENGINEERING MARKET SIZE, BY PLANT GENOME ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 14. GENOME ENGINEERING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GENOME ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GENOME ENGINEERING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. CANADA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 28. CANADA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. CANADA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. MEXICO GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 31. MEXICO GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. MEXICO GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. CHINA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 45. CHINA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. CHINA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. INDIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. INDIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. INDIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. JAPAN GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 54. JAPAN GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. JAPAN GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. THAILAND GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. THAILAND GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. THAILAND GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. DENMARK GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. DENMARK GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. DENMARK GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. EGYPT GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 85. EGYPT GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. EGYPT GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. FINLAND GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. FINLAND GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. FINLAND GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. FRANCE GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. FRANCE GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. FRANCE GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. GERMANY GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. GERMANY GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. GERMANY GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. ITALY GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. ITALY GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. ITALY GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. NORWAY GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. NORWAY GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. NORWAY GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. POLAND GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 112. POLAND GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. POLAND GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. QATAR GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. QATAR GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. QATAR GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. SPAIN GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. SPAIN GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SPAIN GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. TURKEY GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 136. TURKEY GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. TURKEY GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. GENOME ENGINEERING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 145. GENOME ENGINEERING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 146. GENOME ENGINEERING MARKET LICENSE & PRICING

Companies Mentioned

Bluebird Bio, Inc.
CRISPR Therapeutics AG
Danaher Corporation
Editas Medicine, Inc.
GenScript Biotech Corporation
Horizon Discovery Group PLC
Intellia Therapeutics, Inc.
Lonza Group AG
Merck & Co., Inc.
New England Biolabs
Origene Technologies
Precision BioSciences, Inc.
Sangamo Therapeutics, Inc.
Thermo Fisher Scientific Inc.
Transposagen Biopharmaceuticals, Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	191
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 7.32 Billion
Forecasted Market Value ( USD ) by 2030	$ 17.57 Billion
Compound Annual Growth Rate	15.6%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3262EUR$3,374USD£2,802GBP €3624EUR$3,749USD£3,113GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4132EUR$4,274USD£3,549GBP €4591EUR$4,749USD£3,944GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5002EUR$5,174USD£4,297GBP €5558EUR$5,749USD£4,774GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5872EUR$6,074USD£5,044GBP €6525EUR$6,749USD£5,605GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7613EUR$7,874USD£6,539GBP €8458EUR$8,749USD£7,265GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects

The report addresses key questions such as

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Genome Editing Market by Technology (Antisense, CRISPR, Talen), Application (Cell Line Engineering, Genetic Engineering), End User - Forecast 2024-2030

Genome Editing Market Size, Share & Trends Analysis Report By Technology (CRISPR, ZFN, TALEN), By Delivery Method (Ex-vivo, In-vivo), By Application, By Mode, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Global Genome Editing/Genome Engineering Market by Application, Technology, and End User, Regional Outlook - Forecast up to 2030

Genome Editing / Genome Engineering - Global Strategic Business Report

Genome Editing/Genome Engineering Global Market Report 2024

About the Genome Engineering Market